Other: Gadobutrol ( DrugBank: Gadobutrol )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02350426 (ClinicalTrials.gov) | August 12, 2015 | 15/12/2014 | A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques | An Adaptive Design Open Label Pilot Study in Rheumatoid Arthritis Patients to Assess Inflammation Using Molecular Imaging Techniques | Arthritis, Rheumatoid | Other: Gadobutrol;Other: 18F-FDG;Other: 18F-GE-180 | GlaxoSmithKline | Cambridge University Hospitals NHS Foundation Trust | Terminated | 30 Years | 85 Years | All | 10 | Phase 1 | United Kingdom |